Abstract
Photodynamic techniques such as photodynamic diagnosis (PDD), fluorescence-guided tumour resection (FGR) and photodynamic therapy (PDT) are currently undergoing intensive clinical investigations as adjuvant treatment for malignant brain tumours. The following chapter provides an overview on the current clinical data and trials of PDT as well as photosensitizers, technical developments and indications for photodynamic application in neurosurgery. Besides many clinical phase I/II trials for PDT for malignant brain tumours, there are only few controlled clinical trials following tumour resection. Variations in treatment protocols, variation of photosensitizers and light dose make the evaluation scientifically difficult; however there is a clear trend towards prolonging median survival after one single photodynamic treatment as compared to standard therapeutic regimens. According to the meta analysis the median survival after PDT for primary glioblastoma multiforme (WHO grade IV) was 22 months and for recurrent GBM was 9 months as compared to standard conventional treatment, in which it is 15 and 3 months, respectively. Fluorescence-guided resection of the tumour demonstrated significant greater reduction of tumour burden. The combination of PDD/ FGR and intraoperative PDT (“to see and to treat”) offers an exciting approach to the treatment of malignant brain tumours. PDT was generally well tolerated and side effects consisted of occasionally increased intracranial pressure and prolonged skin sensitivity against direct sunlight.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., Lang, F. F., McCutcheon, I. E., Hassenbusch, S. J., Holland, E., Hess, K., Michael, C., Miller, D., and Sawaya, R. (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg, 95, 190–198.
Obwegeser, A., Ortler, M., Seiwald, M., Ulmer, H., and Kostron, H. (1995) Therapy of glioblastoma multiforme: a cumulative experience of 10 years. Acta Neurochir, 137, 29–33.
Radhakrishnan, K., Bohnen, N. I., and Kurland, L. T. (1994) Epidemiology of brain tumors. In: Morantz R. A. and Wals J. W. (eds.) Brain Tumors. New York: Marcel Dekker Inc, pp. 1–18.
Pichlmeier, U., Bink, A., Schackert, G., and Stummer, W. (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol, 10, 1025–1034.
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. (1998) Photodynamic therapy. J Natl Cancer Inst, 17, 889–905.
Triesscheijn, M., Baas, P., Schellens, J. H. M., and Stewart, F. A. (2006) Photodynamic therapy in oncology. Oncologist, 11, 1034–1044.
Mitton, D. and Ackroyd, R. (2008) A brief overview of photodynamic therapy in Europe. Photodiagnosis Photodyn Ther, 5, 103–111.
Kostron, H., Obwegeser, A., and Seiwald, M. (1996) PDT in neurosurgery; a review. J Photochem Photobiol B, 36, 157–168.
Castano, A. P., Demidova, T. N., and Hamblin, M. R. (2004) Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther, 1, 279–293.
Seshadri, M., Bellnier, D. A., Vaughan, L. A., Spernyak, J. A., Mazurchuk, R., Foster, T. H., and Henderson, B. W. (2008) Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clin Cancer Res, 1, 2796–2805.
Angell-Petersen, E., Spetalen, S., Madsen, S. J., Sun, C. H., Peng, Q., Carper, S. W., Sioud, M., and Hirschberg, H. (2006) Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg, 104, 109–117.
Stylli, S. S. and Kaye, A. H. (2006) Photodynamic therapy of cerebral glioma – a review part I – a biological basis. J Clin Neurosci, 13, 615–625.
Eljamel, S. M. (2008) Brain photodiagnosis (PD), fluorescence guided resection (FGR) and photodynamic therapy (PDT): past, present and future. Photodiagnosis Photodyn Ther, 5, 29–35.
Bogaards, A., Varma, A., Zhang, K., Zach, D., Bisland, S. K., Moriyama, E. H., Lilge, L., Muller, P. J., and Wilson, B. C. (2005) Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development. Photochem Photobiol Sci, 4, 438–442.
Kostron, H., Zimmermann, A., and Obwegeser, A. (1998) MTHPC-mediated photodynamic detection for fluorescence guided resection of brain tumors. In: Bogner S.M., Charles S.T., Grundfest W.S., Harrington J.A., Katzir A., Lome L.S., Vannier M.W., and von-Hanwehr R., (eds.) Surgical-Assist Systems. SPIE proceedings-series, Bellingham, WA, US: International-Biomedical-Optics-Society, SPIE, 3262, pp. 259–264.
Kennedy, J. C., Marcus, S. L., and Potier, R. H. (1996) Photodynamic therapy and photodiagnosis using endogenous photosensitisation induced by 5-aminolevulinic acid (ALA): mechanism and clinical results. J Clin Laser Med Surg, 15, 289–304.
Kostron, H., Fiegele, Th., and Akatuna, E. (2006) Combination of FOSCAN® mediated fluorescence guided resection and photodynamic treatment as new therapeutic concept for malignant brain tumors. Laser Med, 24, 285–290.
Zimmermann, A., Ritsch-Marte, M., and Kostron, H. (2001) mTHPC-mediated photodynamic diagnosis of malignant brain tumors. Photochem Photobiol, 74, 611–616.
Eljamel, M. S., Goodman, C., and Moseley, H. (2008) ALA and Photofrin® fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre phase III randomised controlled trial. Lasers Med Sci, 23, 361–367.
Schmidt, M. H., Meyer, G. A., Reichert, K. W., Cheng, J., Krouwer, H. G., Ozkerand, K., and Whelan, H. T. (2004) Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. J Neurooncol, 67, 201–207.
Kessel, D. (2004) Photodynamic therapy: from the beginning. Photodiagnosis Photodyn Ther, 1, 3–7.
Kostron, H., Obwegeser, A., Jakober, R., Zimmermann, A., and Rueck, A. (1998) Experimental and clinical results of mTHPC (Foscan®)– mediated photodynamic therapy for malignant brain tumors. In: Dougherty T.J. (ed.) Optical Methods for Tumor Treatment and Detections: Mechanisms and Techniques in Photodynamics Therapy VII. Bellingham, WA, US: International-Society-for-Optical-Engineering, SPIE, 3247, pp. 40–45.
Obwegeser, A., Jakober, R., and Kostron, H. (1998) Uptake and kinetics of C-14 labelled m-THPC and 5-ALA in C-6 rat glioma model. Br J Cancer, 78, 733–738.
Beck, T. J., Kreth, F. W., Beyer, W., Mehrkens, J. H., Obermeier, A., Stepp, H., Stummer, W., and Baumgartner, R. (2007) Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med, 39, 386–393.
Allison, R. R., Downie, G. H., Cuenca, R., Hu, X. H., Carter, J. H., and Sibata, C. H. (2004) Photosensitizers in clinical PDT. Photodiagnosis Photodyn Ther, 1, 27–42.
Jori, G. (1996) Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J Photochem Photobiol B, 36, 87–93.
Rovers, J. P., Schuitmaker, J. J., Vahrmeijer, A. L., Van-Dierendonck, J. H., and Terpstra, O. T. (1998) Interstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin in a rat model for liver metastases. Br J Cancer, 77, 2098–2103.
Peng, Q., Moan, J., Wei-Ma, L., and Nesland, J. M. (1995) Uptake, localisation and photodynamic effect of meso-tetrahydroxyphenylporphyrine and its corresponding chlorin in normal and tumor tissue of mice bearing mammary carcinoma. Cancer Res, 55, 2260–2266.
Kostron, H., Bellnier, D. A., Lin, C. W., Swarzt, M. R., and Martuza, R. L. (1986) Distribution and retention and phototoxicity of HPD in a rat glioma: intraneoplastic versus intraperitoneal injection. J Neurosurg, 64, 768–774.
Muller, P. J. and Wilson, B. C. (2006) Photodynamic therapy of brain tumors – a work in progress. Lasers Surg Med, 38, 384–389.
Stupp, R., Hegi, M. E., Gilbert, M. R., and Chakravarti, A. (2007) Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol, 25, 4127.
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U. et al. for the European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups and the National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med, 10, 987–996.
Kirveliene, V., Grazeliene, G., Dabkeviciene, D., Micke, I., Kirvelis, D., Juodka, B., and Didziapetriene, J. (2006) Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Cancer Chemother Pharmacol, 57, 65–72.
Hornung, R., Walt, H., Crompton, N. E., Keefe, K. A., Jentsch, B., Perewusnyk, G., Haller, U., and Köchli, O. R. (1998) m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro. Photochem Photobiol, 68, 569–574.
Chen, B., Pogue, B. W., Hoopes, P. J., and Hasan, T. (2005) Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Biol Phys, 61, 1216–1226.
Ferrario, A., Rucker, N., Wong, S., Luna, M., and Gomer, C. J. (2007) Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res, 67, 4989–4995.
Fanuel-Barret, D., Patrice, T., Foultier, M. T., Vonarx-Coinsmann, V., Robillard, N., and Lajat, Y. (1997) Influence of epidermal growth factor on photodynamic therapy of glioblastoma cells in vitro. Res Exp Med, 197, 219–233.
Kessel, D. and Oleinick, N. L. (2009) Chapter 1 initiation of autophagy by photodynamic therapy. Methods Enzymol, 453, 1–16.
Madsen, S. J., Sun, C. H., Tromberg, B. J., Yeh, A. T., Sanchez, R., and Hirschberg, H. (2002) Effects of combined photodynamic therapy and ionizing radiation on human glioma spheroids. Photochem Photobiol, 76, 411–416.
Mang, T. S. (2004) Lasers and light sources for PDT: past, present and future. Photodiagnosis Photodyn Ther, 1, 43–48.
Mang, T. S. (2008) Dosimetric concepts for PDT. Photodiagnosis Photodyn Ther, 5, 217–223.
Krishnamurthy, S., Powers, S. K., Witmer, P., and Brown, T. (2000) Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors. Lasers Surg Med, 27, 224–234.
Kaneko, S., Kobayashi, H., and Kohama, Y. (1999) Stereotactic intratumoral photodynamic therapy on malignant brain tumors, Abstract, International Symposium on Photodynamic Therapy in Clinical Practice, Innsbruck
Bisland, S. K., Lilge, L., Lin, A., Rusnov, R., and Wilson, B. C. (2004) Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol, 80, 222–230.
Hirschberg, H., Sørensen, D. R., Angell-Petersen, E., Peng, Q., Tromberg, B., Sun, C. H., Spetalen, S., and Madsen, S. (2006) Repetitive photodynamic therapy of malignant brain tumors. J Environ Pathol Toxicol Oncol, 25, 261–279.
Thompson, M. S., Johansson, A., Johansson, T., Andersson-Engels, S., Svanberg, S., Bendsoe, N., and Svanberg, K. (2005) Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurement. Appl Opt, 1, 4023–4031.
Kaneko, S., Shírasaka, T., Yoshimuzi, T., Fujimoto, S., Yamouchi, T., Yoshimoto, T., Tokuda, K., Kashiwaba, T., and Kohama, Y. (2002) Fluorescence diagnosis and PDT using two types of photosensitizer. In: Recent progress on clinical and basic research of ALA, Proceedings of 2nd international ALA Symposium, Fukuoka, 17–24.
Kaneko, S. (2008) A current overview: photodynamic diagnosis and photodynamic therapy using 5-ALA in neurosurgery. JJSLSM, 29, 135–146.
Stylli, S. S. and Kaye, A. H. (2006) Photodynamic therapy of cerebral glioma – a review part II – clinical studies. J Clin Neurosci, 13, 709–717.
Marks, P. V., Belchetz, P. E., Saxena, A., Igbaseimokumo, U., Thomson, S., Nelson, M., Stringer, M. R., Holroyd, J. A., and Brown, S. B. (2000) Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial – an early report. Br J Neurosurg, 14, 317–325.
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., and Reulen, H. J. (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol, 7, 392–401.
Henderson, B. W., Busch, T. M., and Snyder, J. W. (2006) Fluence rate as a modulator of PDT mechanisms. Lasers Surg Med, 38, 489–493.
Peng, Q., Warloe, T., Moan, J., Godal, A., Apricena, F., Giercksky, K. E., and Nesland, J. M. (2001) Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of Photofrin in human tumor xenografts. Cancer Res, 61, 5824–5832.
Norum, O. J., Gaustad, J. V., Angell-Petersen, E., Rofstad, E. K., Peng, Q., Giercksky, K. E., and Berg, K. (2009) Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery. Photochem Photobiol Sci, 85, 740–749.
Jain, K. K. (2007) Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert Rev Neurother, 7, 363–372.
Chen, Y., Gryshuk, A., Achilefu, S., Ohulchansky, T., Potter, W., Zhong, T., Morgan, J., Chance, B., Prasad, P. N., Henderson, B. W., Oseroff, A., and Pandey, R. K. (2005) A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy. Bioconjug Chem, 16, 1264–1274.
Jerjes, W., Upile, T., Betz, C. S., El Maaytah, M., Abbas, S., Wright, A., and Hopper, C. (2007) The application of photodynamic therapy in the head and neck. Dent Update, 34, 478–486.
Burch, S., London, C., Seguin, B., Rodriguez, C., Wilson, B. C., and Bisland, S. K. (2009) Treatment of canine osseous tumors with photodynamic therapy: a pilot study. Clin Orthop Relat Res, 22, 44–47.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kostron, H. (2010). Photodynamic Diagnosis and Therapy and the Brain. In: Gomer, C. (eds) Photodynamic Therapy. Methods in Molecular Biology, vol 635. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-697-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-60761-697-9_17
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-696-2
Online ISBN: 978-1-60761-697-9
eBook Packages: Springer Protocols